Group 1 - The company Hanbang Technology (SH 688755) announced on October 28 that it has recognized credit impairment losses and asset impairment losses totaling 12.56 million yuan for the third quarter of 2025, impacting the total profit of the consolidated financial statements by the same amount [1] - The impairment provision is based on the principle of prudence and objectively reflects the actual situation of the company's assets, indicating no harm to the interests of the company and its shareholders, and will not have a significant impact on the company's production and operations [1] - For the first half of 2025, the revenue composition of Hanbang Technology is as follows: small molecule drug separation and purification equipment accounted for 70.99%, large molecule drug separation and purification equipment accounted for 22.94%, and others accounted for 6.07% [1] Group 2 - As of the report date, Hanbang Technology has a market capitalization of 4 billion yuan [1]
汉邦科技：第三季度计提信用减值损失及资产减值损失共计1255.56万元